Expression of Cathepsin B and Cystatin C in Human Breast Cancer

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Surgery today (Print)

• Publication date

  2001-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s005950170126PMID 11381499
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunohistochemical distributions of cathepsin B and basement membrane antigens in human lung adenocarcinoma: association with invasion and metastasis

  2004cited by this paper
• Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.

  1997cited by this paper
• Expression of cysteine protease inhibitors stefin A, stefin B, and cystatin C in human lung tumor tissue.

  1997cited by this paper
• Expression and Roles of Heat Shock Proteins in Human Breast Cancer

  1996cited by this paper
• Expression of pancreatic trypsinogen/trypsin and cathepsin B in human cholangiocarcinomas and hepatocellular carcinomas.

  1995cited by this paper
• Glucocorticoid treatment increases the ability of CRH to induce seizures.

  1994cited by this paper
• Human gastric adenocarcinoma cathepsin B: isolation and sequencing of full-length cDNAs and polymorphisms of the gene.

  1994cited by this paper
• Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival.

  1994cited by this paper
• Quantification of gene expression over a wide range by the polymerase chain reaction.

  1992cited by this paper
• Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B.

  1992cited by this paper
• Stefins and lysosomal cathepsins B, L and D in human breast carcinoma

  1992cited by this paper
• Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease.

  1991cited by this paper
• Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma.

  1991cited by this paper
• Efficient purification of TIMP-2 from culture medium conditioned by human hepatoma cell line, and its inhibitory effects on metalloproteinases and in vitro tumor invasion.

  1991cited by this paper
• The role of cathepsin L in malignant transformation.

  1990cited by this paper
• Cathepsin B and cystatins: evidence for a role in cancer progression.

  1990cited by this paper
• Structure and expression of the human cystatin C gene.

  1990cited by this paper
• The role of cathepsin L in malignant transformation.

  1990cited by this paper
• Cathepsin B and L activities in gastric cancer tissue: correlation with histological findings.

  1989cited by this paper
• Enhanced levels of cathepsin B mRNA in murine tumors

  1989cited by this paper
• Cysteine protease activities and tumor development in human colorectal carcinoma.

  1989cited by this paper
• Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues.

  1989cited by this paper
• A comparison of four cathepsins (B, L, N and S) with collagenolytic activity from rabbit spleen.

  1988cited by this paper
• Elevation of tissue cathepsin B and L activities in gastric cancer.

  1987cited by this paper
• Cathepsin B: association with plasma membrane in metastatic tumors.

  1986cited by this paper
• Cathepsin B-like cysteine proteinase activity in sputum and bronchoalveolar lavage samples: relationship to inflammatory cells and effects of corticosteroids and antibiotic treatment.

  1985cited by this paper
• The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors.

  1984cited by this paper
• The place of human γ-trace (cystatin C) amongst the cysteine proteinase inhibitors

  1984cited by this paper
• Lysosomal cathepsin B: correlation with metastatic potential.

  1981cited by this paper
• Metastatic potential correlates with enzymatic degradation of basement membrane collagen

  1980cited by this paper
• Characterization of a thiol proteinase secreted by malignant human breast tumours.

  1980cited by this paper
• Modulation of Urokinase-type Plasminogen Activator and Ovarian Cancer Cell Invasion by in Vitro Inhibition of Updated Version Citing Articles E-mail Alerts Inhibition of in Vitro Ovarian Cancer Cell Invasion by Modulation of Urokinase- Type Plasminogen Activator and Cathepsin B

  year unknowncited by this paper

• Cysteine Cathepsins and Their Diagnostic Role in Breast Cancer

  2024cites this paper
• The Role of Cathepsin B in Pathophysiologies of Non-tumor and Tumor tissues: A Systematic Review

  2023cites this paper
• Camouflaged liposomes by 11A4-nanobody for co-delivery of cisplatin and nitroxoline in breast cancer tumors: An in vitro/in vivo study

  2022cites this paper
• Cystatin C in addition to creatinine for better assessment of glomerular renal function decline in people with HIV receiving antiretroviral therapy

  2022cites this paper
• Cysteine Cathepsins in Breast Cancer: Promising Targets for Fluorescence-Guided Surgery

  2022cites this paper
• CTSB Knockdown Inhibits Proliferation and Tumorigenesis in HL-60 Cells

  2021cites this paper
• Advances in biomedical and pharmaceutical applications of protein-stabilized gold nanoclusters.

  2020cites this paper
• The potential of cystatin C as a predictive biomarker in breast cancer

  2020cites this paper
• Exploiting Proteases for Cancer Theranostic through Molecular Imaging and Drug Delivery.

  2020cites this paper
• Application of nanotechnology to target and exploit tumour associated proteases.

  2019cites this paper
• Interplay of ERα binding and DNA methylation in the intron-2 determines the expression and estrogen regulation of Cystatin A in breast cancer cells

  2019cites this paper
• Cathepsin B defines leader cells during the collective invasion of salivary adenoid cystic carcinoma

  2019influential citation
• Recent advances in ultra-small fluorescent Au nanoclusters toward oncological research.

  2019cites this paper
• Aberrant cystatin-C expression in blood from patients with breast cancer is a suitable marker for monitoring tumor burden

  2018cites this paper
• On the role of cystatin C in cancer progression

  2018cites this paper
• Utility of cystatin C as a potential bladder tumour biomarker confirmed by surface plasmon resonance technique

  2018cites this paper
• Cysteine cathepsins as a prospective target for anticancer therapies-current progress and prospects.

  2018cites this paper
• Autophagy-related genes are induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid via the activation of cathepsin B in human breast cancer cells

  2017cites this paper
• Evaluation of Serological Indicators and Glomerular Filtration Rate Equations in Chinese Cancer Patients

  2017cites this paper
• Increasing Cystatin C and Cathepsin B in Serum of Colorectal Cancer Patients.

  2017cites this paper
• Efficient expression and purification of biologically active human cystatin proteins.

  2016cites this paper
• PEG-peptide drug carrier systems with enzymatic degradation units

  2016influential citation
• Expression of cystatin C and its effect on EC9706 cells in esophageal carcinoma.

  2015cites this paper
• Charakterystyka i znaczenie proteinaz cysteinowych w procesie nowotworzenia

  2015cites this paper
• Renal function evaluation in patients with cancer who were scheduled to receive carboplatin or S-1

  2015cites this paper
• The activity and localization patterns of cathepsins B and X in cells of the mouse gastrointestinal tract differ along its length

  2014cites this paper
• Cellular Uptake of Cystatin C. Subcellular localisation and intracellular effects of a secreted cysteine protease inhibitor

  2013cites this paper
• Evaluation of the Renal Function Using Cystatin C Level in the Patients Receiving Cisplatin-Based Chemotherapy

  2013cites this paper
• Immune-independent and label-free fluorescent assay for Cystatin C detection based on protein-stabilized Au nanoclusters.

  2013cites this paper
• Cathepsin B as a cancer target

  2013cites this paper
• Cathepsins and Other Proteases in Tumor Angiogenesis

  2013cites this paper
• Microdialysis Combined with Proteomics for Protein Identification in Breast Tumor Microenvironment In Vivo

  2011cites this paper
• Comprehensive proteome analysis of malignant pleural effusion for lung cancer biomarker discovery by using multidimensional protein identification technology.

  2011cites this paper
• Association of cystatin C with prostasomes in human seminal plasma.

  2011cites this paper
• Surface Plasmon Resonance Imaging (SPRI) sensor for cystatin determination based on immobilized papain.

  2011cites this paper
• It is all about proteases: from drug delivery to in vivo imaging and photomedicine.

  2011cites this paper
• Cystatin C as a Parameter of Glomerular Filtration Rate in Patients with Ovarian Cancer

  2010cites this paper
• Prognostic biomarkers in ovarian carcinoma cyst fluid.

  2010cites this paper
• Identification of breast cancer biomarkers in transgenic mouse models: A proteomics approach

  2010cites this paper
• The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer

  2010cites this paper
• Cathepsin S and its inhibitor cystatin C: imbalance in uveal melanoma.

  2009cites this paper
• A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047

  2009cites this paper
• Cathepsins B, L and cystatin C in cyst fluid of ovarian tumors

  2009influential citation
• Cysteine Cathepsins and Cystatins as Cancer Biomarkers

  2008cites this paper
• Circulating cathepsin K and cystatin C in patients with cancer related bone disease: clinical and therapeutic implications.

  2008cites this paper
• CYSTEINE PROTEASES, ENDOGENOUS INHIBITORS AND PROTEASES/INHIBITORS RATIO IN HUMAN COLORECTAL CANCER PROGRESSION CYSTEINOWE PEPTYDAZY, ENDOGENNE INHIBITORY CYSTEINOWYCH PEPTYDAZ I STOSUNEK PROTEAZ/INHIBITORY W PROGRESJI NOWOTWORU PRZEWODU POKARMOWEGO U LUDZI

  2008cites this paper
• [Cystatin C as a marker of glomerular filtration rate in patients with ovarian cancer].

  2008cites this paper
• Cathepsin B, Cathepsin H, Cathepsin X and Cystatin C in Sera of Patients with Early-Stage and Inflammatory Breast Cancer

  2008cites this paper
• Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer.

  2008cites this paper
• Relation of cystatin C and cathepsin B expression to the pathological grade and invasion of human gliomas

  2007cites this paper
• Epigenetic mechanisms of gene regulation in human breast cancer

  2007cites this paper
• Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms.

  2006cites this paper
• Mechanistic biomarkers for cytotoxic acute kidney injury

  2006cites this paper
• DNA methylation-dependent silencing of CST6 in human breast cancer cell lines

  2006cites this paper
• Expression analysis of cystatin C and M in laser-capture microdissectioned human breast cancer cells--a preliminary study.

  2005cites this paper
• Expression of cystatin C in clinical human colorectal cancer tissues.

  2005cites this paper
• Clinicopathologic significance of cystatin C expression in gliomas.

  2005cites this paper
• Expression of Cathepsin B and microvascular density increases with higher grade of astrocytomas

  2004cites this paper
• Cathepsins in basal cell carcinomas: activity, immunoreactivity and mRNA staining of cathepsins B, D, H and L

  2004cites this paper
• Cysteine cathepsins in human cancer

  2004cites this paper
• The potentials of MS-based subproteomic approaches in medical science: the case of lysosomes and breast cancer.

  2004cites this paper
• Cysteine proteases as disease markers.

  2004cites this paper
• Cathepsin D is up‐regulated in inflammatory bowel disease macrophages

  2004cites this paper
• Biochemistry and Clinical Role of Human Cystatin C

  2004cites this paper
• CHARACTERIZATION OF CATHEPSIN B mRNA AND PROTEIN EXPRESSION, ENZYMATIC ACTIVITY AND CELLULAR LOCALIZATION FOLLOWING CONTUSION SPINAL CORD INJURY IN RATS

  2004cites this paper
• Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis

  2004cites this paper
• The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer.

  2004cites this paper
• Prediction of biologically significant components from microarray data: Independently Consistent Expression Discriminator (ICED)

  2003cites this paper
• Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy.

  2003cites this paper
• Mechanism of action of mammalian cystatins Studies of inhibition of cysteine endo- and exopeptidases by cystatins A and C

  2003cites this paper
• Mechanism of action of mammalian cystatins

  2003cites this paper
• Monoclonal antibody drug immunoconjugates for targeted treatment of cancer

  2003cites this paper
• Prognostic Significance of the Combination of Biological Parameters in Breast Cancer

  2003cites this paper
• Cystatin 11: a new member of the cystatin type 2 family.

  2002cites this paper
• Natural inhibitors of tumor-associated proteases

  2002cites this paper
• Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells

  2002cites this paper
• Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases.

  2001cites this paper
• Oncotargets and Therapy Dovepress Dovepress Clinical Significance of Serum Cathepsin B and Cystatin C Levels and Their Ratio in the Prognosis of Patients with Esophageal Cancer

  year unknowncites this paper